Anti-prothrombin but not “pure” Anti-cardiolipin Antibodies Are Associated with the Clinical Features of the Antiphospholipid Antibody Syndrome

M. Sorice; V. Pittoni; A. Circella; R. Misasi; F. Conti; A. Longo; G.M. Pontieri; G. Valesini

doi:10.1055/s-0037-1615454

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1998; 80(04): 713-715
DOI: 10.1055/s-0037-1615454

Letters to the Editor

Schattauer GmbH

Anti-prothrombin but not “pure” Anti-cardiolipin Antibodies Are Associated with the Clinical Features of the Antiphospholipid Antibody Syndrome

M. Sorice

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

V. Pittoni

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

A. Circella

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

R. Misasi

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

F. Conti

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

A. Longo

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

G.M. Pontieri

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

,

G. Valesini

¹Dipartimento di Medicina Sperimentale e Patologia, Clinica Medica 1, Università “La Sapienza”, Roma, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta₂-glycoprotein I (apolipoprotein H) Proc Natl Acad Sci USA. 1990 87. 4120-4.
2 Oosting JD, Derksen RHWM, Bobbink IWG, Hackengt TM, Bouma BN, De Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C and protein S - an explanation for their pathogenetic mechanism?. Blood 1993; 81: 2618-25.
3 Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants.. Thromb Haemost 1995; 74: 1120-5.
4 Pengo VA, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.. Thromb Haemost 1996; 75: 721-4.
5 Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Relationship of anti-β₂ glycoprotein I and anti-prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.. Thromb Haemost 1998; 78: 1008-14.
6 Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A. Anticardiolipin, anti-beta(₂)-glyco-protein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.. J Rheumatol 1998; 24: 1710-5.
7 Sanmarco M, Soler C, Christides C, Raoult D, Weiller PJ, Gerolami V, Bernard D. Prevalence and clinical significance of IgG isotype anti-beta_2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies.. J Lab Clin Med 1998; 129: 499-506.
8 Horbach DA, von Oort E, Donders RCJM, Derksen RHWM, de Groot PG. Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus. Comparison between Different Assays for the Detection of Antiphospholipid Antibodies.. Thromb Haemost 1996; 76: 916-24.
9 Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with Systemic Lupus Erythematosus.. Clin Immunol Immunopath 1996; 80: 16-22.
10 Palosuo T, Virtamo J, Haukka J, Taylor PR, Aho K, Puurunen M, Vaarala O. High Antibody Levels to Prothrombin Imply a Risk of Deep Venous Thrombosis and Pulmonary Embolism in Middle-aged Men.. Thromb Haemost 1998; 78: 1178-82.
11 Lafeuillade A, Sorice M, Griggi T, Pellegrino P, Geoffroy M, Profizi N. Role of autoimmunity in protein S deficiency during HIV-1 infection.. Infection 1994; 22: 201-3.
12 Sorice M, Griggi T, Circella A, Lenti L, Arcieri P, Di Nucci GD, Mariani G. Protein S antibodies in acquired protein S deficiencies.. Blood 1994; 83: 2383-4.
13 Sorice M, Arcieri P, Griggi T, Circella A, Misasi R, Lenti L, Di Nucci GD, Mariani G. Inhibition of Protein S by Autoantibodies in Patients with Acquired Protein S Deficiency.. Thromb Haemost 1996; 75: 555-9.
14 Sorice M, Circella A, Griggi T, Garofalo T, Nicodemo G, Pittoni V, Pontieri GM, Lenti L, Valesini G. Anticardiolipin and anti-β₂-GPI are Two Distinct Populations of Autoantibodies.. Thromb Haemost 1996; 75: 303-8.
15 Tan EN, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Shaller JG, Talal N, Winchester RG. The 1982 revised criteria for the classification of Systemic Lupus Erythematosus.. Arth Rheum 1982; 25: 1271-7.
16 Hughes GRV. The anticardiolipin syndrome.. Clin Exp Rheumatol 1985; 3: 285-6.
17 Sorice M, Griggi T, Circella A, Garofalo T, D’Agostino F, Pittoni V, Pontieri GM, Lenti L, Valesini G. Detectioin of antiphospholipid antibodies by immunostaining on thin layer chromatography plates.. J Immunol Methods 1994; 173: 49-54.
18 MacDonald RI, MacDonald RC. Assembly of phospholipid vesicles bearing sialoglycoprotein from erytrocyte membrane.. J Biol Chem 1975; 250: 9206-14.
19 Vermylen J, Arnout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?. J Lab Clin Med 1992; 120: 10-2.